SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-162164
Filing Date
2006-08-04
Accepted
2006-08-04 13:55:11
Documents
10
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 507959
2 CONFIRMATION OF OTC CONVERTIBLE NOTE HEDGE RELATED TO 2011 NOTES dex101.htm EX-10.1 89620
3 CONFIRMATION OF OTC CONVERTIBLE NOTE HEDGE RELATED TO 2013 NOTES dex102.htm EX-10.2 89885
4 CONFIRMATION OF OTC WARRANT TRANSACTION dex103.htm EX-10.3 100716
5 CONFIRMATION OF OTC WARRANT TRANSACTION dex104.htm EX-10.4 101322
6 STOCK PURCHASE AGREEMENT DATED JUNE 6, 2006 dex105.htm EX-10.5 449767
7 EMTRICITABINE MANUFACTURING SUPPLY AGREEMENT dex106.htm EX-10.6 147478
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER, AS REQUIRED BY RULE 13A -14(A) dex311.htm EX-31.1 7779
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER, AS REQUIRED BY RULE 13A -14(A) dex312.htm EX-31.2 7815
10 CERTIFICATION OF CEO AND CFO AS REQUIRED BY SECTION 1350 dex32.htm EX-32 3013
  Complete submission text file 0001193125-06-162164.txt   1506751
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19731 | Film No.: 061005167
SIC: 2836 Biological Products, (No Diagnostic Substances)